| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/05/2001 | CA2386029A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | CA2386025A1 Vaccine against neisseria infection |
| 04/05/2001 | CA2386013A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
| 04/05/2001 | CA2385888A1 Engineering antibodies that bind irreversibly |
| 04/05/2001 | CA2385884A1 26 human secreted proteins |
| 04/05/2001 | CA2385743A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | CA2385633A1 Paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 04/05/2001 | CA2385609A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2384981A1 P-glycoproteins and uses thereof |
| 04/05/2001 | CA2384662A1 41 human secreted proteins |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/05/2001 | CA2384584A1 38 human secreted proteins |
| 04/05/2001 | CA2382808A1 22196, a novel human aminopeptidase |
| 04/05/2001 | CA2381771A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/04/2001 | EP1088900A1 Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications |
| 04/04/2001 | EP1088892A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 04/04/2001 | EP1088890A2 Recombinant BPI proteins, uses of BPI proteins, and methods of preparing same |
| 04/04/2001 | EP1088228A2 Cartilage resorption assays |
| 04/04/2001 | EP1088095A1 Novel molecules of the t110-related protein family and uses thereof |
| 04/04/2001 | EP1088079A2 Nek-related and bub1-related protein kinases |
| 04/04/2001 | EP1088074A1 Origin of replication and methods of use |
| 04/04/2001 | EP1088072A2 Prostate cancer-associated genes |
| 04/04/2001 | EP1088071A1 94 human secreted proteins |
| 04/04/2001 | EP1088069A1 Angiostatin-binding protein |
| 04/04/2001 | EP1088068A1 Immunomodulator polypeptide, zsig57 |
| 04/04/2001 | EP1087997A2 Monoclonal antibodies directed against the g3bp protein, and uses |
| 04/04/2001 | EP1087994A1 INTERACTION OF p27(KIP1) WITH FKBP-12 |
| 04/04/2001 | EP1087993A1 Fas peptides and antibodies for modulating apoptosis |
| 04/04/2001 | EP1087984A2 acpS |
| 04/04/2001 | EP1087792A1 NrdD |
| 04/04/2001 | EP1087784A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
| 04/04/2001 | CN1290302A Protein production in transgenic alfalfa plants |
| 04/04/2001 | CN1290301A Single-chain bifunctional glycoprotein hormones |
| 04/04/2001 | CN1289854A Human proteasome subunit protein and its coding sequence |
| 04/04/2001 | CN1289853A Human micronuclear ribonucleoprotein isomer and its coding sequence |
| 04/04/2001 | CN1289852A Human nif gene homogenous protein and its coding sequence |
| 04/04/2001 | CN1289851A Human micronuclear ribomucleoprotein specific 40KD protein isomer and its coding sequence |
| 04/04/2001 | CN1289850A Human heat shock protein and its coding sequence |
| 04/04/2001 | CN1289849A Human protein isomer induced by tumor nectosis factor and its coding sequence |
| 04/04/2001 | CN1289848A Human interleukin enhancer binding factor protein isomer and its coding sequency |
| 04/04/2001 | CN1289847A Human Heteronuclear ribonucleoprotein isomer and its coding sequence |
| 04/04/2001 | CN1289846A Human precursor protein of transition receptor potential site and its coding sequence |
| 04/04/2001 | CN1289845A Human protein isomor of transition receptor potentia site and its coding sequence |
| 04/04/2001 | CN1063969C Process for preparing pharmaceutically composition containing poly peptides |
| 04/03/2001 | US6211342 Multivalent MHC complex peptide fusion protein complex for stimulating specific T cell function |
| 04/03/2001 | US6211336 Ataxia-telangiectasia gene |
| 04/03/2001 | US6211334 Cell-cycle regulatory proteins, and uses related thereto |
| 04/03/2001 | US6211161 UDP-N-acetylmuramoyl-l-alanine:D-glutamate ligase (MURD) of staphylococcus aureus |
| 04/03/2001 | US6211148 Antimicrobial peptides from bovine neutrophis |
| 04/03/2001 | US6211146 60A protein-induced morphogenesis |
| 04/03/2001 | US6210962 Nucleotide and peptide sequences of an isolate of the hepatitis C virus, diagnostic and therapeutic applications thereof |
| 04/03/2001 | US6210944 Phosphoribosyl transferase from Staphylococcus aureus |
| 04/03/2001 | US6210929 Fusion protein of furin with catalytic center and c-terminal deletion, flexible peptide spacer, and histidine-tag affinity peptide; for proteolytic processing/activation of recombinant proteins |
| 04/03/2001 | US6210920 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 04/03/2001 | US6210917 By treating methylthioadenosine phosphorylase deficient cells with adenine synthesis inhibitor to deplete the target cells of adenosine 5'-triphosphate |
| 04/03/2001 | US6210914 Method to identify proteins which bind to integrin regulatory proteins |
| 04/03/2001 | US6210906 Contacting sample with monoclonal antibody or fragment against lipoprotein(a) which has been immobilized on a solid support, forming immunocomplexes, and determining amount bound; diagnosis of cardiovascular disorders |
| 04/03/2001 | US6210904 Diagnosing for risk of thromocytopenia by detecting absence of association of monoclonal antibody with glycoprotein iib/iia receptor:glycoprotein iib/iia receptor antagonist complex |
| 04/03/2001 | US6210903 Amino acid sequence which is optionally modified and biotinylated |
| 04/03/2001 | US6210902 Using two immunoassays to measure two different type 1 collagen breakdown products of defined amino acid sequence in sample and forming an index representing the difference in results; diagnosis of bone disorders such as osteoporosis |
| 04/03/2001 | US6210901 Modified hepatitis c virus amino acid sequence which binds to an antibody; for screening blood samples |
| 04/03/2001 | US6210682 Immunization against rotavirus infection or rotavirus disease by administering to a subject a peptide nsp4 114-135, a peptide nsp4 120-147, or a toxoid thereof are disclosed. |
| 04/03/2001 | US6210675 Post-transfusional non-a non-b hepatitis viral polypeptide |
| 04/03/2001 | US6210674 GreA from Staphylococcus aureus |
| 04/03/2001 | US6210671 Complementarity determining regions corresponding to mouse dreg-55 donor immunoglobulin; heavy and light chain variable region frameworks corresponding to gal antibody human acceptor immunoglobulin heavy and light chain frameworks |
| 04/03/2001 | US6210670 Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin |
| 04/03/2001 | US6210669 Methods and compositions for immunomodulation |
| 04/03/2001 | US6210668 Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies |
| 04/03/2001 | US6210654 Jak kinases and regulation of cytokine signal transduction |
| 04/03/2001 | CA2211120C Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/03/2001 | CA2163755C Dna encoding prostaglandin receptor ep1 |
| 04/03/2001 | CA2153180C Interleukin 4 signal transducers and binding assays |
| 03/30/2001 | CA2283538A1 New hev antigenic peptide and methods |
| 03/29/2001 | WO2001022085A1 Method of fractional measurement of soluble cd14 protein |
| 03/29/2001 | WO2001021830A1 Nuclease inhibitor cocktail |
| 03/29/2001 | WO2001021828A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 03/29/2001 | WO2001021817A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 03/29/2001 | WO2001021815A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021814A1 Heparanase-2, a member of the heparanase protein family |
| 03/29/2001 | WO2001021812A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/29/2001 | WO2001021800A1 Monoclonal antibody 3f1h10 neutralising vhsv (viral haemorrhagic septicaemia virus) |
| 03/29/2001 | WO2001021799A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021797A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 03/29/2001 | WO2001021796A2 Gl50 molecules and uses therefor |
| 03/29/2001 | WO2001021791A2 Stargazin-like neuronal ca2+-channel gamma subunit polypeptides |
| 03/29/2001 | WO2001021788A1 MAST CELL-SPECIFIC SIGNAL TRANSDUCING MOLECULES AND cDNAS THEREOF |
| 03/29/2001 | WO2001021784A2 Pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021663A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021658A1 32 human secreted proteins |
| 03/29/2001 | WO2001021654A2 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021652A1 Methods for identifying an agent that corrects defective protein folding |
| 03/29/2001 | WO2001021644A2 Wheat dp proteins and uses thereof |
| 03/29/2001 | WO2001021641A1 Compositions and methods for the diagnosis and treatment of immune disorders |
| 03/29/2001 | WO2001021215A1 Cell based assay |
| 03/29/2001 | WO2001021205A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 03/29/2001 | WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 03/29/2001 | WO2001021196A1 Method and compositions for inhibiting adhesion formation |
| 03/29/2001 | WO2001021192A2 Methods for diagnosis and therapy of hematological and virus-associated malignancies |